ImmunityBio, Inc.
DE ˙ DB ˙ US45256X1037
6,33 € ↑0,20 (3,26%)
2026-06-04
AKTIENPREIS
SecurityDE:26CA / ImmunityBio, Inc.
InstitutionFmr Llc
Latest Disclosed Ownership30,704 shares
Latest Disclosed Value $ 235,501
Fmr Llc reports 126.11% increase in ownership of 26CA / ImmunityBio, Inc.

On May 15, 2026 - Fmr Llc filed a 13F-HR form disclosing ownership of 30,704 shares of ImmunityBio, Inc. (DE:26CA) valued at $201,418 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 13,579 shares of ImmunityBio, Inc.. This represents a change in shares of 126.11% during the quarter. The current value of the position is $194,356 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IMMUNITYBIO COM 45256X103 30,704 17,125 126.11 236 803.85 0.0000
2026-02-17 2025-12-31 13F IMMUNITYBIO COM 45256X103 13,579 2,665 24.42 27 0.00 0.0000
2025-11-13 2025-09-30 13F IMMUNITYBIO COM 45256X103 10,914 -3,227 -22.82 27 -29.73 0.0000
2025-08-14 2025-06-30 13F IMMUNITYBIO COM 45256X103 14,141 -123,772 -89.75 37 -91.08 0.0000
2025-05-12 2025-03-31 13F IMMUNITYBIO COM 45256X103 137,913 24,072 21.15 415 42.61 0.0000
2025-02-13 2024-12-31 13F IMMUNITYBIO COM 45256X103 113,841 105,689 1,296.48 291 870.00 0.0000
2024-11-13 2024-09-30 13F IMMUNITYBIO COM 45256X103 8,152 -3,608 -30.68 30 -59.46 0.0000
2024-08-13 2024-06-30 13F IMMUNITYBIO COM 45256X103 11,760 -7,380 -38.56 74 -27.45 0.0000
2024-05-13 2024-03-31 13F IMMUNITYBIO COM 45256X103 19,140 1,926 11.19 103 18.60 0.0000
2024-02-13 2023-12-31 13F IMMUNITYBIO COM 45256X103 17,214 2,333 15.68 86 244.00 0.0000
2023-11-13 2023-09-30 13F IMMUNITYBIO COM 45256X103 14,881 9,749 189.96 25 78.57 0.0000
2023-08-11 2023-06-30 13F IMMUNITYBIO COM 45256X103 5,132 224 4.56 14 75.00 0.0000
2023-08-11 2023-03-31 13F/A-1 IMMUNITYBIO COM 45256X103 4,908 -4,537 -48.04 9 -82.98 0.0000
2023-05-11 2023-03-31 13F IMMUNITYBIO COM 45256X103 4,908 -4,537 9 0.0000
2023-02-13 2022-12-31 13F IMMUNITYBIO COM 45256X103 9,445 -414 -4.20 48 -4.08 0.0000
2022-11-10 2022-09-30 13F IMMUNITYBIO COM 45256X103 9,859 850 9.44 49 48.48 0.0000
2022-08-12 2022-06-30 13F IMMUNITYBIO COM 45256X103 9,009 -100,425 -91.77 33 -94.63 0.0000
2022-05-13 2022-03-31 13F IMMUNITYBIO COM 45256X103 109,434 109,434 614 0.0000
2022-02-14 2021-09-30 13F/A-1 IMMUNITYBIO COM 45256X103 0 -100 -100.00 0 -100.00
2021-11-15 2021-09-30 13F IMMUNITYBIO COM 45256X103 0 -100 0
2021-08-13 2021-06-30 13F IMMUNITYBIO COM 45256X103 100 98 4,900.00 1 0.0000
2021-05-14 2021-03-31 13F IMMUNITYBIO COM 45256X103 2 2 -98.00 0 -100.00 0.0000
2018-08-10 2018-06-30 13F NANTKWEST COM 63016Q102 0 -230,213 -100.00 0 -100.00
2018-05-14 2018-03-31 13F NANTKWEST COM 63016Q102 230,213 -1,038,937 -81.86 896 -84.28 0.0001
2018-02-12 2017-12-31 13F NANTKWEST COM 63016Q102 1,269,150 -364,049 -22.29 5,698 -36.34 0.0007
2017-11-13 2017-09-30 13F NANTKWEST COM 63016Q102 1,633,199 -102,601 -5.91 8,950 -32.07 0.0011
2017-08-29 2017-06-30 13F/A-1 NANTKWEST COM 63016Q102 1,735,800 -10,700 -0.61 13,175 112.50 0.0016
2017-08-11 2017-06-30 13F NANTKWEST COM 63016Q102 1,735,800 -10,700 13,175
2017-05-11 2017-03-31 13F NANTKWEST COM 63016Q102 1,746,500 -418,445 -19.33 6,200 -49.93 0.0008
2017-02-10 2016-12-31 13F NANTKWEST COM 63016Q102 2,164,945 0 0.00 12,383 -26.48 0.0017
2016-11-14 2016-09-30 13F NANTKWEST COM 63016Q102 2,164,945 -115,632 -5.07 16,843 18.74 0.0022
2016-08-11 2016-06-30 13F NANTKWEST COM 63016Q102 2,280,577 -48,818 -2.10 14,185 -25.92 0.0019
2016-05-16 2016-03-31 13F NANTKWEST COM 63016Q102 2,329,395 -163,400 -6.55 19,148 -55.68 0.0026
2016-02-12 2015-12-31 13F NANTKWEST COM 63016Q102 2,492,795 964,495 63.11 43,200 146.66 0.0058
2015-11-10 2015-09-30 13F NANTKWEST COM 63016Q102 1,528,300 1,528,300 17,514 0.0025
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.